Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Invasive lobular breast carcinoma
ADR ID BADD_A09193
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.10      Breast neoplasms malignant and unspecified (incl nipple)
16.10.01      Breast and nipple neoplasms malignant
16.10.01.014      Invasive lobular breast carcinoma
21      Reproductive system and breast disorders
21.05      Breast disorders
21.05.01      Benign and malignant breast neoplasms
21.05.01.022      Invasive lobular breast carcinoma
Description Not Available
MedDRA Code 10073096
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Lobular breast carcinoma invasive | Lobular breast carcinoma stage II | Lobular breast carcinoma stage III | Lobular breast carcinoma stage IV | Lobular carcinoma of breast | Lobular carcinoma recurrent | Lobular carcinoma stage II | Lobular carcinoma stage III | Lobular carcinoma stage IV | Invasive lobular breast carcinoma | Invasive lobular breast carcinoma recurrent | Invasive pleomorphic lobular carcinoma
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00680Dimethyl fumarate0.001000%
BADD_D00914Fludarabine0.000112%
BADD_D01257Letrozole0.000711%
BADD_D01281Levonorgestrel0.001655%
BADD_D01480Mitoxantrone0.000112%
BADD_D01913Ranitidine0.000038%
BADD_D02236Tofacitinib0.000362%
BADD_D02464Fingolimod0.000482%
The 1th Page    1    Total 1 Pages